Literature DB >> 8748819

Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts.

B M Borgbjerg1, F Gjerris, M J Albeck, S E Børgesen.   

Abstract

Postoperative infections are major complications of cerebrospinal fluid (CSF) shunting in the treatment of hydrocephalus and other conditions with obstructed CSF circulation. In a retrospective study 884 first-time shunted patients with hydrocephalus operated on in the years 1958-1989 were investigated with special reference to the infection rate and to the influence of the following variables: time period, age of the patient, education of the neurosurgeon, length and time of the operation and the exact placement of the distal drain. The overall infection rate for all implanted CSF shunts was 7.4% (5.7-9.3%) and the acute rate of infection was 6.2% (4.6-7.9%). The rate of infection was virtually constant for all variables with the exception of the education of the neurosurgeon. Neurosurgical trainees particularly had a significantly higher rate of infection. Shunt infection is still a major complication. The infection rate has not declined in recent decades. It is not possible to relate any main cause to the infection rate. The literature recommends removal of the infected shunt combined with antibiotics. The use of prophylactic antibiotics is still controversial. No prospective, double-blind studies, including a sufficiently large number of patients to evaluate this issue, exist today.

Entities:  

Mesh:

Year:  1995        PMID: 8748819     DOI: 10.1007/bf01411427

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  53 in total

1.  Follow-up analysis of ventriculoperitoneal and ventriculoatrial shunts for hydrocephalus.

Authors:  R J Ignelzi; W M Kirsch
Journal:  J Neurosurg       Date:  1975-06       Impact factor: 5.115

2.  Prophylactic antibiotic in shunt surgery.

Authors:  G Lohmann; E Cardoso; D Pillalamari; K Gintautiene; M R Chaudhry; J Gintautas; A R Abadir
Journal:  Proc West Pharmacol Soc       Date:  1991

3.  Cerebrospinal fluid shunting for hydrocephalus: a retrospective analysis.

Authors:  J D Metzemaekers; J W Beks; J S van Popta
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

4.  Decreased risk of infection in cerebrospinal fluid shunt surgery using prophylactic antibiotics: a case-control study.

Authors:  B C Walters; H J Hoffman; E B Hendrick; R P Humphreys
Journal:  Z Kinderchir       Date:  1985-12

5.  Results of trimethoprim-sulfamethoxazole prophylaxis in ventriculostomy and shunting procedures. A double-blind randomized trial.

Authors:  G C Blomstedt
Journal:  J Neurosurg       Date:  1985-05       Impact factor: 5.115

6.  Antibiotic single-dose prophylaxis of shunt infections.

Authors:  J Blum; M Schwarz; D Voth
Journal:  Neurosurg Rev       Date:  1989       Impact factor: 3.042

7.  Complications of ventriculo-peritoneal shunting and a critical comparison of the three-piece and one-piece systems.

Authors:  A J Raimondi; J S Robinson; K Kuwawura
Journal:  Childs Brain       Date:  1977

8.  The effect of cephalothin prophylaxis on postoperative ventriculoperitoneal shunt infections.

Authors:  M J Rieder; T C Frewen; R F Del Maestro; A Coyle; S Lovell
Journal:  CMAJ       Date:  1987-05-01       Impact factor: 8.262

9.  Oxacillin prophylaxis in cerebrospinal fluid shunt procedures: results of a randomized open study in 60 hydrocephalic patients.

Authors:  M Djindjian; M J Fevrier; G Otterbein; J C Soussy
Journal:  Surg Neurol       Date:  1986-02

10.  Long-term results after ventriculoatrial and ventriculoperitoneal shunting for infantile hydrocephalus.

Authors:  T R Keucher; J Mealey
Journal:  J Neurosurg       Date:  1979-02       Impact factor: 5.115

View more
  33 in total

Review 1.  Cerebrospinal fluid diversion devices and infection. A comprehensive review.

Authors:  R Gutiérrez-González; G R Boto; A Pérez-Zamarrón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-30       Impact factor: 3.267

2.  Idiopathic intracranial hypertension is not benign: a long-term outcome study.

Authors:  Hanne M Yri; Marianne Wegener; Birgit Sander; Rigmor Jensen
Journal:  J Neurol       Date:  2011-10-19       Impact factor: 4.849

3.  The impact of antibiotic-impregnated catheters on shunt infection in children and neonates.

Authors:  Caroline Hayhurst; Richard Cooke; Dawn Williams; Jothy Kandasamy; Donncha F O'Brien; Conor L Mallucci
Journal:  Childs Nerv Syst       Date:  2007-10-26       Impact factor: 1.475

4.  Few Patient, Treatment, and Diagnostic or Microbiological Factors, Except Complications and Intermittent Negative Cerebrospinal Fluid (CSF) Cultures During First CSF Shunt Infection, Are Associated With Reinfection.

Authors:  Tamara D Simon; Nicole Mayer-Hamblett; Kathryn B Whitlock; Marcie Langley; John R W Kestle; Jay Riva-Cambrin; Margaret Rosenfeld; Emily A Thorell
Journal:  J Pediatric Infect Dis Soc       Date:  2013-08-26       Impact factor: 3.164

5.  Analysis of the potential risk of central intravenous lines and/or total parenteral nutrition with ventriculoatrial shunts.

Authors:  Ian K White; Kashif A Shaikh; Obed M Nyarenchi; Madan G Kundu; Joel C Boaz; Daniel H Fulkerson
Journal:  Childs Nerv Syst       Date:  2015-02-25       Impact factor: 1.475

Review 6.  Shunt Devices for Neurointensivists: Complications and Management.

Authors:  G Smith; J Pace; A Scoco; G Singh; K Kandregula; S Manjila; C Ramos-Estebanez
Journal:  Neurocrit Care       Date:  2017-10       Impact factor: 3.210

Review 7.  Shunt infections: a review and analysis of a personal series.

Authors:  Santosh Mohan Rao Kanangi; Chidambaram Balasubramaniam
Journal:  Childs Nerv Syst       Date:  2018-07-05       Impact factor: 1.475

8.  Antibiotic-impregnated catheters reduce ventriculoperitoneal shunt infection rate in high-risk newborns and infants.

Authors:  Giovanni Raffa; Lucia Marseglia; Eloisa Gitto; Antonino Germanò
Journal:  Childs Nerv Syst       Date:  2015-03-28       Impact factor: 1.475

9.  Relationship of causative organism and time to infection among children with cerebrospinal fluid shunt infection.

Authors:  Matthew R Test; Kathryn B Whitlock; Marcie Langley; Jay Riva-Cambrin; John R W Kestle; Tamara D Simon
Journal:  J Neurosurg Pediatr       Date:  2019-05-03       Impact factor: 2.375

10.  Protective effect of rifampicin and clindamycin impregnated devices against Staphylococcus spp. infection after cerebrospinal fluid diversion procedures.

Authors:  Raquel Gutiérrez-González; Gregorio R Boto; Cristina Fernández-Pérez; Náyade del Prado
Journal:  BMC Neurol       Date:  2010-10-12       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.